首页> 美国卫生研究院文献>Aging (Albany NY) >Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis
【2h】

Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis

机译:圆形RNA Circmboat2通过MiR-1271-5P / MTOR轴促进前列腺癌进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients with advanced prostate cancer (PCa) have poor prognosis. Circular RNAs (circRNAs) regulate biological processes in a variety of cancers, but the precise roles of circRNAs in PCa are poorly understood. Herein, we identified a novel circRNA, termed circMBOAT2 (has_circ_0007334), which was significantly overexpressed in PCa tissues and cell lines. Overexpression of circMBOAT2 was associated with high Gleason score, advanced pathological T stage, and poor prognosis. Overexpression of circMBOAT2 promoted proliferation, migration, and invasion of PCa cells , and enhanced tumorigenesis and metastasis . Mechanistically, circMBOAT2 overexpression upregulated the expression of mTOR by acting as a decoy for miR-1271-5p, resulting in the activation of the PI3K/Akt pathway, ultimately promoting the progression of PCa. Importantly, application of an inhibitor of mTOR significantly antagonized circMBOAT2-mediated PCa tumorigenesis . circMBOAT2 promotes proliferation and metastasis of PCa through miR-1271-5p/mTOR axis-mediated activation of the PI3K/Akt pathway. In summary, our findings uncover a molecular mechanism in the progression of PCa and indicate that circMBOAT2 may be a useful prognostic biomarker and therapeutic target in PCa.
机译:前列腺癌(PCA)的患者预后差。圆形RNA(Circrnas)调节各种癌症的生物过程,但Circrnas在PCA中的精确作用被理解得很差。在此,我们鉴定了一种新的Circrna,称为循环釜2(has_circ_000734),其在PCA组织和细胞系中显着过表达。 Circmboat2的过度表达与高艾奇赛评分,晚期病理T阶段和预后差有关。 LiCMBOAT2的过度表达促进PCA细胞的增殖,迁移和侵袭,并增强肿瘤鉴定和转移。机械地,循环植物2过表达通过用作MIR-1271-5P的诱饵来提高MTOR的表达,导致PI3K / AKT途径的激活,最终促进PCA的进展。重要的是,将MTOR抑制剂的应用显着拮抗循环介导的PCA肿瘤瘤。 Circmboat2通过MIR-1271-5P / MTOR轴介导的PI3K / AKT途径的激活促进PCA的增殖和转移。总之,我们的研究结果发现了PCA的进展中的分子机制,表明Circmboat2可以是PCA中有用的预后生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号